您的位置: 首页 > 2016年7月 第47卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

卵巢上皮性癌治疗前后血小板计数变化的临床分析

Clinical Analysis of blood platelet count in epithelial ovarian cancer pre and post treatment

来源期刊: 广州医药 | 70-72 发布时间:2021-12-02 收稿时间:2025/11/13 16:58:36 阅读量:33
作者:
关键词:
卵巢上皮性癌血小板计数临床病理特征
DOI:
10.3969/j.issn.1000-8535.2016.04.023
收稿时间:
2016-03-02 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨卵巢上皮性癌患者治疗前后外周血血小板计数(PLT)变化的临床意义。方法 采用全血细胞自动分析仪检测115例卵巢上皮性癌患者治疗前和经过有效治疗后的97例患者血小板计数增多检出率的比较,并分析卵巢上皮性癌患者治疗前血小板计数增多与临床病理因素的相关性。结果 33.04%卵巢上皮性癌患者治疗前伴有血小板计数增多,经过有效治疗后,血小板计数增多者降为9.28%,较治疗前明显下降,差异有统计学意义(P<0.05)。卵巢上皮性癌患者治疗前血小板增多与FIGO分期、残余肿瘤灶直径、腹水细胞学和临床疗效相关(P<0.01)。结论 血小板作为一种简单、经济、灵敏的临床常用指标,监测其表达对于预测卵巢癌临床疗效和预后评估具有临床价值。
1、 ATACAG T. Diagnostic value of thrombocytosis and high CA-125 level in women with adnexal masses[J]. Eur J Gynaecol Oncol, 2012,33(5):517-520. ATACAG T. Diagnostic value of thrombocytosis and high CA-125 level in women with adnexal masses[J]. Eur J Gynaecol Oncol, 2012,33(5):517-520.
2、 STONE RL, NICK AM, MCNEISH LA, et al. Paraneoplastic thrombocytosis in ovarian cancer[J]. N Engl J Med,2012,366(7):610-618. STONE RL, NICK AM, MCNEISH LA, et al. Paraneoplastic thrombocytosis in ovarian cancer[J]. N Engl J Med,2012,366(7):610-618.
3、 庞晓燕,张颐,孟祥凯,等.血小板增多对上皮性卵巢癌预后的影响[J]. 中国医科大学学报,2014,43(9):711-714. 庞晓燕,张颐,孟祥凯,等.血小板增多对上皮性卵巢癌预后的影响[J]. 中国医科大学学报,2014,43(9):711-714.
4、 LI AJ, MADDEN AC,CASS I,et al. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma[J]. Gynecologic Oncology,2004,9(2):211-214. LI AJ, MADDEN AC,CASS I,et al. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma[J]. Gynecologic Oncology,2004,9(2):211-214.
5、 BRAHMER JR, TYKODI SS, CHOW LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer[J]. N EngI J Med, 2012, 366(26):2455-2465. BRAHMER JR, TYKODI SS, CHOW LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer[J]. N EngI J Med, 2012, 366(26):2455-2465.
6、 GUNGOR T,KANAT PEKTAS M,SUCAK A,et al. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors [J]. Arch Gynecol Obstet,2009,279(1):53-56. GUNGOR T,KANAT PEKTAS M,SUCAK A,et al. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors [J]. Arch Gynecol Obstet,2009,279(1):53-56.
7、 VOLOSHIN T, VOEST EE, SHAKED Y. The host immunological response to cancer therapy:An emerging concept in tumor biology[J]. Exp Cell Res,2013,319(11):1687-1695. VOLOSHIN T, VOEST EE, SHAKED Y. The host immunological response to cancer therapy:An emerging concept in tumor biology[J]. Exp Cell Res,2013,319(11):1687-1695.
8、 BAMBACE NM, HOLMES CE. The platelet contribution to cancer progression[J]. Journal of Thrombosis and Haemostasis,2011,9(2) :237-249. BAMBACE NM, HOLMES CE. The platelet contribution to cancer progression[J]. Journal of Thrombosis and Haemostasis,2011,9(2) :237-249.
9、 METINDIR J, GULAY BD. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma[J]. J Cancer Res Clin Oncol, 2009,32(3):125-128. METINDIR J, GULAY BD. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma[J]. J Cancer Res Clin Oncol, 2009,32(3):125-128.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录